The development of avian cutaneous appendages, feathers and scales, is known to arise from the epithelial-mesenchymal interaction. Here we show that FGF10 is associated with this developmental process as an early signal from mesenchymal cells underlying nascent cutaneous placodes. Expression of Fgf10 was detected in the mesenchymal cells underneath the developing placodes. Forced expression of Fgf10 in the femoral skin suppressed expression of Shh and a zinc finger gene snail-related (cSnR), while induced expression of Bmp2 in the interbud region, resulting in thickening of the epidermal layer. Furthermore, forced expression of Fgf10 in the foot skin caused marked ingrowings of the epidermis. The cells in the epidermal ingrowings expressed b-catenin, proliferating cell nuclear antigen, and an epidermal stem cell marker p63. These results support the idea that FGF10 is a mesenchymally derived stimulator of epidermal development through crosstalk with bone morphogenetic protein (BMP), b-catenin, and other signaling pathways. q
Introduction
Development of the cutaneous appendages is an example of an epithelial-mesenchymal interaction. In birds, the integument can give rise to two types of appendages; scales and feathers. In the chick, while most of the body is covered with feathers that are grouped in defined tracts or pterylae, the feet bear scales, and some areas, referred to as apteria, remain bare. The significant part of our present knowledge of the early establishment of cutaneous patterns comes from studies of chick feather buds (Mayerson and Fallon, 1985; Noramly and Morgan, 1998 ; reviewed by Dhouailly et al., 1998; Wolpert, 1998; Chuong et al., 2000) .
Feather primordia begin their development in the chick embryo at 6 days of incubation. They first appear as dense regions on the chick skin surface, and develop in a welldefined temporal order. Initially, the feather-forming region is a columnar epidermis overlying a loose mesenchyme.
This first indication of bud specification is the local thickening of the ectoderm to form a disk-like structure called the epidermal placode. Dermal cells then migrate to form a dermal condensation beneath the placode and subsequently proliferate to form a protruding feather bud. The dense dermis is either instructive or permissive for the initiation of bud formation and can induce additional changes in the placodes. Reciprocal signaling between these structures results in the coordinated outgrowth of the bud. Such interactions between the mesenchyme and the overlying ectoderm, known as epithelial-mesenchymal interactions, play a key role in feather morphogenesis.
Several molecules involved in feather formation have been identified, including members of the bone morphogenetic protein (BMP) (Zou and Niswander, 1996; Jung et al., 1998; Noramly and Morgan, 1998; Patel et al., 1999) and their antagonists (Patel et al., 1999; Botchkarev et al., 1999; Ohyama et al., 2001) , transforming growth factor b 2 (TingBerreth and Chuong, 1996a) , fibroblast growth factors (FGFs) (Song et al., 1996; Widelitz et al., 1996; Ohuchi et al., 2000a) and their receptors (Noji et al. 1993; Noramly and Morgan, 1998) , sonic hedgehog (Shh) Ting-Berreth and Chuong, 1996b; Morgan et al., 1998) , Wnts (Tanda et al., 1995; Widelitz et al., 1999) and their receptors (Kawakami et al., 2000) , b-catenin (Noramly et al., 1999; Widelitz et al., 2000) , Notch/Delta families (Chen et al., 1997; Viallet et al., 1998) , the neural cell adhesion molecule (NCAM) (Chuong and Edelman, 1985) , and lunatic fringe (Chen and Chuong, 2000) .
Although many genes expressed in the feather as well as scale placodes have been identified so far, early mesenchymal signaling factors have not been fully identified yet. We found that Fgf10, known as an essential mesenchymal factor during multiorgan development (Ohuchi et al., 1997 (Ohuchi et al., , 2000b Min et al., 1998; Sekine et al., 1999; Makarenkova et al., 2000 ; reviewed by Hogan, 1999) , was expressed in mesenchymal cells of the feather-and scale-forming region. To elucidate the roles of FGF10 during cutaneous appendage formation, Fgf10 was misexpressed in the chick embryonic skin with a retrovirus system. The resultant changes in the expression of cutaneous marker genes and gross morphology of the skin appendages support the idea that FGF10 is involved in epithelial-mesenchymal interaction as a mesenchymal factor during cutaneous appendage formation and progression of epidermal stem cells.
Results

Fgf10 is expressed in the mesenchymal cells of feather and scale primordia
We first examined the expression pattern of Fgf10 during cutaneous appendage formation in the chick embryo. In the feather-forming region, the expression of Fgf10 was first observed at stage 29 (6-6.5 days of incubation; Fig. 1A ) as spots in the nascent feather buds in distinct feather tracts along the mid-dorsum, thighs, shoulders, and wing margins. At stages 29-31, the number of spotty expressions of Fgf10 increased in each femoral tract, reflecting the appearance of feather rudiments in the tracts (Fig. 1A-D) . A transverse section reveals that Fgf10 is expressed in the mesenchymal cells underlying the feather placode (Fig. 1E) . By stage 36, the expression of Fgf10 was downregulated in the feather buds (data not shown), while a lower level of Fgf10 expression became observed in the ridges of nascent scutate scales (Fig. 1F) . Thus, Fgf10 is expressed by the mesenchymal cells at the time and site of placode formation for both feather and scale appendages in the chick.
2.2. Forced expression of Fgf10 in the femoral skin caused thickening of the epidermal layer and perturbation of the feather tract
The timing and location of the Fgf10 expression suggests that FGF10 may play a role in the initial phase of cutaneous appendage formation. This hypothesis was tested by forced expression of rat Fgf10 in the developing chick skin using a replication competent retroviral vector. We prepared RCASFgf10 expressing cells and implanted the cells into the proximal leg mesenchyme, resulting in infection of Fgf10-virus to the femoral feather tracts. The infection of the virus was confirmed by in situ hybridization with a probe for rat Fgf10 (Fig. 4A) . In resultant embryos harvested at embryonic day 12 (E12), we observed deformed feather buds in large areas of the femoral tracts on the operated side ( Fig. 2B ) (22 out of 32 embryos (69%) were affected). Abnormal feathers were bulbous and wide (Fig. 2D) , instead of long, tapering filaments as observed in the normal contralateral thigh ( Fig.  2A, C) . The nearly featherless area was observed in the middle region (Fig. 4A) , and abnormal feather buds appeared to surround this area (Figs. 2D and 3B) . Such effects were not observed when alkaline phosphatase-producing cells were implanted as control ðn ¼ 11Þ (data not shown). Sections of the infected areas revealed that the epidermal layer thickened (Fig. 2F, H ) ( Fig. 3C ; P , 0:001) as compared with the corresponding normal epidermis (Fig. 2E, G) . Thus, it is likely that FGF10 may stimulate proliferation of the epidermal cells in the feather-forming region and its overexpression perturbs feather tract formation.
2.3. Fgf10-overexpression in the femoral skin suppresses expression of Shh and cSnR while it upregulates expression of Bmp2 and Fgfr2
To clarify the mechanism of FGF10 action, we analyzed expression patterns of other genes, such as Bmp2, Shh, and Fgfr2, after Fgf10-misexpression. Fgfr2 was found to be expressed in the interbud region and suppressed in the buds (Noji et al., 1993; Noramly and Morgan, 1998; Fig. 4B) , thus it is a marker for the areas of feather inhibition. We observed that forced expression of Fgf10 induced the expression of Fgfr2 in the bud region, resulting in the loss of its periodical pattern (four out of five cases) (Fig. 4C) . On the other hand, Bmp2 is usually expressed in the epidermal layer of the bud region (Jung et al., 1998; Fig. 4D, D 0 ). We observed diffuse expression of Bmp2 after Fgf10 overexpression (six out of ten) (Fig. 4E ), which was confirmed by the corresponding section (Fig. 4E 0 ; n ¼ 2). In contrast, Shh expression, which is normally seen on the tip of the feather placode and distal epithelium of the nascent bud Ting-Berreth and Chuong, 1996b) , was suppressed in the affected femoral region (four out of six) (Figs. 4G and 4F as control) . We saw the expression of one more marker gene, chick snail-related (cSnR). This gene is a homologue of Drosophila snail, encoding a zinc finger protein (Isaac et al., 1997) . Since cSnR had been implicated in the association of FGF10 in limb initiation (Isaac et al., 2000) , we first examined whether cSnR was also expressed during feather bud formation. We found that cSnR was expressed in the mesenchyme of normal nascent feather buds as distinct tracts along the mid-dorsum, shoulders, wing margins, and thighs ( Fig. 4H, J) , as well as scale ridges (Fig. 4K) . However, forced expression of Fgf10 in the femoral skin suppressed the cSnR expression, as is the case for Shh (four out of five) (Fig. 4I) . These results indicate that exogenous Fgf10 in the femoral skin suppresses expression of Shh and cSnR while it upregulates expression of Bmp2 and Fgfr2.
To examine whether Fgf10-misexpression in the femoral skin decreases the number of feather placodes, we calculated the total number of Shh or cSnR-expressing spots in Fgf10-misexpressed thighs. Compared with that of contralateral control thighs, the number of femoral feather primordia expressing these genes was significantly decreased ( Fig.  3D ; P ¼ 0:02 for Shh, P ¼ 0:004 for cSnR). Thus, alteration of the gene expression patterns of Bmp2, Shh, cSnR, and Fgfr2, leading to the loss of their periodical expressions, may be related to perturbation of feather bud formation caused by forced expression of Fgf10 in the femoral skin.
Forced expression of Fgf10 perturbs cutaneous appendage formation and causes abnormal ingrowings of the epidermal layer
It was reported that local application of exogenous FGFs to cultured skin explants can cause the formation of feather buds in normally apteric regions of wild-type skin and in the defective pterylae of the scaleless mutant that do not normally make feathers (Song et al., 1996; Widelitz et al., 1996) . These findings prompted us to examine whether FGF10 could initiate feather bud formation in the scale-forming region. To see this, we implanted Fgf10-virus producing cells in the future foot mesenchyme at stage 20. By E12, Fgf10 was overexpressed in the whole distal leg bud, as shown in Fig. 5A . In the normal scale-forming region, Shh is expressed in the scutate scales found on the anterior metatarsal shank and dorsal part of the toes (Fig. 5B ). In contrast, Shh expression was not observed in the Fgf10-misexpressed foot ( Fig. 5C ) (six out of ten), resulting in the formation of periodical ingrowings of the epithelial layer ( Fig. 5E ). At E18, the large scutate scales (Fig. 5F ) were converted into small periodical protrusions ( Fig. 5G ) (nine out of ten).
To further dissect the phenotype of Fgf10-misexpressed foot skin, we examined the distribution of NCAM and Tenascin-C by immunostaining. It has been reported that NCAM is expressed in the dermal papilla and marginal plates of feathers, but it is weakly expressed in scale mesenchyme (Chuong and Edelman, 1985; Shames et al., 1991; Jiang and Chuong, 1992; Fig. 6A, C, I) . Tenascin is also expressed in the dermal papilla and present on the basement membrane between the barb ridge plates and pulp, as well as beneath the feather sheath, whereas it is expressed more intensely by the anterior mesenchyme at the epithelial-mesenchymal border in scales (Jiang and Chuong, 1992; Shames et al., 1994; Fig. 6B, D, J) . In the Fgf10-misexpressed foot skin, NCAM was diffusely distributed in the mesenchyme, but no NCAM-positive dermal papilla-like structures were found (Fig. 6K , M), while Tenascin protein was distinctly detected at the epithelialmesenchymal border without anterior-posterior gradient (Fig. 6L, N) . For comparison, we also examined localization of these molecules in Fgf10-misexpressed feather region. NCAM protein was diffusely detected in the Fgf10-misexpressed feather mesenchyme (Fig. 6E, G) , whereas Tenascin was present at the epithelial-mesenchymal border with the thickened epidermis (Fig. 6F, H) , as is found in Fgf10-overexpressed scale region. Thus, the Fgf10-misexpressed scale as well as feather regions exhibit rather high expression levels of NCAM and Tenascin, that is more like those found in feather follicles. However, their expression patterns are significantly different from those found in normal feather or scale primordia verifying that Fgf10-misexpression perturbs cutaneous appendage formation and that Fgf10-misexpressed skin does not exhibit the identity of feathers or scales.
2.5. Fgf10-induced epithelial ingrowings express b -catenin and exhibit characteristics of a stratified basal layer It has been reported that b-catenin is expressed in the ectodermal and dermal cells at the time of feather placode formation (Noramly et al., 1999) . Furthermore, forced expression of b-catenin induced epidermal invaginations and placode-like structures in the scale epidermis . Since this phenotype looks like that found in the Fgf10-misexpressed foot skin, we examined the expression of b-catenin in the Fgf10-misexpressed foot skin. In the normal apteric skin, a high level of b-catenin protein is The number of feather primordia per 6 mm 2 was calculated in the femoral skin at E12. The skin of Fgf10-treated embryos shows a significant decrease in the number of feather primordia compared with contralateral control skin. P , 0:001. (B) The skin of Fgf10-treated embryos shows a significant decrease in the percentage of feather primordia in advanced stages of development compared with control skin. *P , 0:05. As for stages of feather development, see Section 4. (C) Thickness of epidermis in Fgf10-treated and contralateral control thighs at E12. Fgf10-treated epidermis was significantly thickened compared with the control. P , 0:001. (D) The number of feather primordia in femoral region, expressing Shh or cSnR at E7.5 (stages 31-33). The skin of Fgf10-treated embryos shows a significant decrease in the number of feather primordia compared with contralateral control skin. P , 0:05 for Shh, and P , 0:01 for cSnR.
detected in the epidermis abutting the dermis (Fig. 7A, D) . In the Fgf10-misexpressed skin, b-catenin protein was accumulated in the stratified epidermis and the dermis surrounding the epidermal invaginations (Fig. 7G ). Both nuclear and membrane-associated staining patterns of b-catenin were observed in the Fgf10-induced ingrowings (Fig. 7J) . We next examined the proliferation state of the abnormal epithelial thickening, using proliferating cell nuclear antigen (PCNA) as a marker. PCNA is a cofactor for DNA polymerase, whose staining shows the presence of cell proliferation in the basal layer of the apteric and scale epidermis, and in the feather collar region (Fig. 7B, E and data not shown) . In the Fgf10-induced invaginations, intense PCNA staining was observed in the multi-layered epidermal cells (Fig. 7H, K) , indicating the basal cell character of the abnormal ingrowings. p63, a member of the tumor suppressor gene family, is also expressed by the basal layer cells of the mammalian epidermis and chick developing skin (Yang et al., 1999; Yasue et al., 2001 , Fig. 7C, F) . In the Fgf10-misexpressed skin, p63-expressing cells were accumulated in the epidermal ingrowings (Fig. 7I, L) . These results show that FGF10 can upregulate the expression of b-catenin and p63, and that Fgf10-induced epidermal ingrowings exhibit characteristics of a stratified basal layer.
Discussion
3.1. FGF10 is a stimulator for proliferation of epidermis in the chick embryonic skin: does FGF10 have any roles in cutaneous placode formation?
Our primary purpose for this study was to determine whether FGF10 had a role as a mesenchymal stimulator in the formation of cutaneous placodes, as Fgf10 was expressed in the mesenchymal cells at the time and location of the feather and scale placode formation. Contrary to our expectation, forced expression of Fgf10 in the pteric (feather-or scale-forming) regions does not promote feather or scale formation. Instead, exogenous Fgf10 induces a marked epidermal proliferation in the pteric regions. It is known that FGF10 binds with high affinity to an isoform of FGF receptor type 2 (FGFR2), FGFR2b (Igarashi et al., 1998) . Fgfr2b is expressed on the epidermis and epithelial components of various developing tissues (Orr-Urtreger et al., 1993; De Moerlooze et al., 2000) . Thus, it is reasonable to think that exogenous Fgf10 in the mesenchyme specifically acts on the epidermis via FGFR2b, resulting in epithelial thickening. If it is the case, could we relate this experimental result to the endogenous role of FGF10 during cutaneous placode formation? It is noteworthy that epithelial thickening after Fgf10 overexpression exhibits ingrowing and never outgrows. Normal cutaneous appendage formation requires coordinated ingrowings and outgrowings, mediated by balanced epithelial and mesenchymal proliferations. Considering the epithelial distribution of FGFR2b, forced expression of Fgf10 may specifically stimulate epithelial proliferation, but not enough mesenchymal proliferation, leading to striking epidermal ingrowings. Thus, although the gain-of-function experiment employed here cannot faithfully reiterate the endogenous function of FGF10, it is most likely that FGF10 in the nascent dermis underneath the developing placodes has a distinct role in initial epidermal thickening in the chick embryo. This function of FGF10 seems to be utilized in other developmental processes, such as lacrimal gland formation in the mouse eye Govindarajan et al., 2000) . We have also found that the FGF10-encoding retrovirus can induce epidermal proliferation in the vicinity of the chick embryonic eye (H.T., H.O., unpublished observation). These observations suggest that FGF10 may be a permissive stimulator for epidermal proliferation in vertebrates. 
Spatiotemporal regulation of Fgf10 expression is required for coordinated cutaneous appendage formation
Alteration of the gene expression patterns of Shh, cSnR, Bmp2, and Fgfr2 after Fgf10 overexpression indicates that FGF10 signaling can modulate transcription of these signaling molecules during feather development. Forced expression of Fgf10 leads to upregulation of Bmp2 and Fgfr2, and downregulation of Shh and cSnR, implying that FGF10 induces the expression of inhibitors and suppresses the activators for feather formation (Jung et al., 1998) . Hence, overexpression of Fgf10 in the femoral tracts causes enlargement of interbud regions while it perturbs feather bud development. It is noteworthy that endogenous Fgf10 is expressed transiently in the future feather mesenchyme. We think that, for normal coordinated development of feather buds, Fgf10 expression must be downregulated by the appropriate developmental stage. Under the experimental conditions employed in this study, Fgf10-expressing cells are widely distributed in the dermis as well as the epidermis of the virus-infected area at E18 (data not shown). It is conceivable that the constitutive expression of Fgf10 perturbs periodical expression of the morphogenetic genes, resulting in the cessation of normal feather development. Thus, endogenous FGF10 may act as a trigger for epithelial appendage formation in the early induction stage and spatiotemporal regulation of Fgf10 expression is probably required for coordinated cutaneous development in subsequent stages. It is further notable that even if the periodical expression of Shh, Bmp2, cSnR, and Fgfr2 is lost by exogenous Fgf10, epidermal thickenings exhibit a certain periodicity (Fig. 2F) , implying that the fundamental periodicity of the skin is not affected by the forced expression of Fgf10.
3.3. Crosstalk among FGF10, BMPs, and other (b -catenin, NCAM, Tenascin) signaling pathways during cutaneous appendage formation This study shows that FGF10 could upregulate Bmp2 expression. On the other hand, our preliminary data show that a BMP antagonist Noggin can alter the expression pattern of Fgf10 (H.T. and H.O., unpublished data), indicating a crosstalk between FGF10 and BMP signaling. Furthermore, the expression of b-catenin and p63 is upregulated in the Fgf10-induced epithelial ingrowings. b-catenin is a protein that serves a dual role in intercellular junction formation and in transcriptional regulation of Wnt signaling. Wnt signaling inhibits phosphorylation and the subsequent degradation of b-catenin, allowing cytoplasmic pools of bcatenin to enter the nucleus, bind to members of the Lef1/ Tcf family of DNA-binding proteins, and activate target genes. In the Fgf10-misexpresed chick skin, a greater number of cells are stained with the b-catenin antibody in a membrane-associated manner than in a nuclear pattern (Fig. 7D) . Thus, it is likely that FGF10 can induce the expression of b-catenin in the epidermal cells independently of Wnt signaling, and that b-catenin expressing cells are probably involved in cell adhesion with cadherin under FGF10 signaling. It has been reported that b-catenin protein becomes concentrated in the nucleus concomitantly with the differentiation of chick feather or mouse hair cells Merrill et al., 2001) . Therefore, it is highly probable that Fgf10-induced epidermal ingrowings are in an undifferentiated state.
NCAM is an adhesion molecule, affecting intracellular signaling (reviewed by Crossin and Krushel, 2000) , whereas Tenascin-C is a multifunctional, extracellular matrix glycoprotein, whose transcription is controlled by multiple soluble factors (reviewed by Jones and Jones, 2000) . It has been shown that NCAM and Tenascin are expressed during chick feather development and their involvement in feather formation includes initial placode formation, anteriorposterior patterning, and elongation of feather buds (Jiang and Chuong, 1992) . This study shows modification of NCAM and Tenascin expressions by exogenous Fgf10, suggesting a crosstalk among the signaling pathways of FGF10 and these adhesion or extracellular molecules during cutaneous appendage formation.
FGF10 per se is not involved in establishment of the identity of cutaneous appendages
It is thought that the identity of cutaneous appendages is determined by the mesenchyme and affected by the timing and level of expression of key signaling molecules, such as Shh, Wnt, FGF, Notch, and BMPs (reviewed by Carroll et al., 2001 ). In the case of FGF10, although feathers seem to develop in regions with a higher level of Fgf10 expression than scales, forced expression of Fgf10 was not sufficient to induce feathers in the scale-forming region. What prevents FGF10 from inducing feather formation in the scale region? It may be explained as follows: an excess level of Bmp expression induced by FGF10 hinders a feather-favored condition. This interpretation stems from the idea that the level of BMP signaling determines the identities of scales and feathers (Zou and Niswander, 1996; reviewed by Carroll et al., 2001 ); higher level of Bmp expression perturbs feather formation. In this sense, it appears that the action of FGF10 per se is not instructive for establishment of the identity of cutaneous appendages.
Implications of FGF10 in the formation of the basal cell compartment of the epidermis
The similarity in phenotypes between Fgf10-null mice and those of p63 prompted us to explore the interaction between FGF10 and p63: For example, both mutant mice exhibit a severe truncation of the limb and the absence of eyelids (Yang et al., 1999; Min et al., 1998; Sekine et al., 1999) . p63 is expressed in the basal, or progenitor, cells of several epithelial structures including the epidermis and the importance of p63 function in epithelial differentiation is revealed by the absence of skin and related appendages in p63-null mice (Yang et al., 1999) . Thus, it is thought that p63 is required in stem cell division for the epidermis and associated cutaneous structures. In addition, it was recently reported that p63 distinguishes human adult keratinocyte stem cells from their transient amplifying progeny, and thus p63 is a molecular marker for epidermal stem cells (Pellegrini et al., 2001 ; reviewed by Bianco and Robey, 2001) . Our study shows that FGF10 can induce a marked expression of p63 in the developing epidermis. Harada et al. (2002) reported that FGF10 signaling is sufficient and required for regulating cell proliferation of mouse incisor stem cells. Thus, FGF10 may be involved in regulating progression of stem cells for the epithelial structures during development. In the case of skin, however, p63 is expressed in the basal layer of Fgf10-null epidermis (Ohuchi et al., 2000b; H.T., H.O., unpublished data) . Therefore, FGF10 is sufficient to induce cell division of stem cells in the epidermis, but other FGFs seem to compensate for this function in the absence of FGF10. Finally, Fgf10-induced proliferation of basal cells within the epidermis is reminiscent of histological features seen in a basal cell carcinoma (reviewed by Bale and Yu, 2001) . Thus, it is conceivable that FGF10 might function as a mesenchymal stimulator to basal cell carcinomas in addition to stem cell populations in human adult tissues.
Concluding remarks
In Fig. 8 , we summarized possible molecular targets of FGF10 in normal and experimental conditions, deduced from this study. Taken together with the expression in the mesenchyme underlying the nascent placodes, FGF10 functions as a stimulator for epidermal proliferation and thus is a candidate mesenchymal initiator for cutaneous placodes.
The overexpression study of Fgf10 shows that spatiotemporal regulation of Fgf10 expression is required for subsequent development of cutaneous appendage morphogenesis. FGF10 and other multiple factors such as BMP, b-catenin, and p63 are involved in cutaneous appendage formation and progression of epidermal stem cells. Apart from reported functions on other FGF members, FGF10 could not induce feather formation in the scale-forming region under the experimental condition here. This supports the idea that FGF10 is a permissive, but not an instructive factor, for epidermal growth. Further elucidation of FGF10 signaling cascade will provide a profound understanding of signals during cutaneous development as well as oncogenesis and regenerative processes.
Experimental procedures
Recombinant retroviral construction, production, and infection
Construction of replication-competent, avian sarcoma virus-rat Fgf10 (RCAS-Fgf10) has been described previously (Ohuchi et al., 1997) . Specific pathogen-free (SPF) chick embryos were obtained from Nisseiken Co., Japan. SPF-chick embryo fibroblast (CEF) cultures were grown and transfected with retroviral vector DNA as described (Ohuchi et al., 1997) . The supernatants of CEF cultures transfected with the viral DNAs were aliquoted and stored at 2808C until further use.
Cell implants
Flasks (12.5 cm 2 ) containing SPF-CEFs infected with either RCAs encoding alkaline phosphatase (Fekete and Cepko, 1993) or RCAS-Fgf10 were grown to 100% confluence, lightly trypsinized and processed for preparation of cell implants as described by Riddle et al. (1993) .
Whole-mount in situ hybridization
Chick embryos were fixed in 4% paraformaldehyde and processed for whole-mount in situ hybridization as described (Ohuchi and Noji, 2000) . Digoxigenin-labeled antisense RNA probes were generated for Fgf10 (Ohuchi et al., 1997) , Shh, Bmp2 , Fgfr2 (Noji et al., 1993) , and cSnR (provided by J. Cooke). Whole embryos were observed using a Leica zoom stereomicroscope. Selected embryos were processed for paraffin sections according to the standard procedure. Sections were observed with Nomarski optics using a Leica DMR microscope.
Experimental manipulations of chick embryos
Fertilized chicken eggs were incubated at 388C and the embryos were staged according to Hamburger and Hamilton (1951) . RCAS-Fgf10 expressing cells were implanted into the hindlimb mesenchyme of SPF chick embryos at stage 20. Embryos at appropriate stages were harvested and either processed for in situ hybridization or analysis of skin appendages. Each experimental set was repeated at least three times. For histological analysis, Hematoxylin and Eosin staining was performed according to the standard procedure.
Immunohistochemistry
Monoclonal antibodies against p63 (provided by F. McKeon; also purchased from SantaCruz), PCNA Fig. 8 . Potential molecular targets for FGF10 during cutaneous placode induction (A) and progression of basal cell compartment (B) in normal (upper panels) and Fgf10-overexpressed conditions (lower panels). (A) It is postulated that inhibitory and activating interactions among these factors are balanced in normal developmental processes. However, when FGF10 is overexpressed, excess expression of Bmp2 is induced and periodical patterns of gene expression disappear, resulting in epidermal thickening at the expense of normal feather morphogenesis. It is unclear whether suppression of Shh expression by FGF10 is through the inhibitory signal of BMP2 or not. Since target molecules for FGF10 primarily exist on the epithelium, its inhibitory effect on cSnR expression may be indirect. (B) FGF10 in the mesenchyme (dermis) acts on the overlying basal layer of the epidermis, where p63, b-catenin, and PCNA are expressed. When Fgf10 is overexpressed, the cells that express the three molecules have prevailed and marked epidermal ingrowings are observed. Cell proliferation, adhesion, and progression of basal cell compartment are considerably stimulated by exogenous Fgf10.
(DAKO), Tenascin-C, and NCAM (Developmental Studies Hybridoma Bank) were used at 1:100, 1:100, 1:1, and 1:5 dilution, respectively. A polyclonal antibody against b-catenin (Sigma, 1:100) was used. Primary antibodies were visualized using the Vectastain Universal Quick Kit and NovaRed substrate Kit (Vector Laboratories).
Quantitative histomorphometry
The number of feather primordia per 6 mm 2 of epidermis was calculated in digital images of Fgf10-misexpressed thighs at E12, and was compared with that of contralateral control thigh ðn ¼ 5Þ (Fig. 3A) . The number of feather primordia per length unit of epidermis was calculated in skin paraffin sections of Fgf10-misexpressed thighs at E12, and was compared with that of contralateral control thigh ðn ¼ 3Þ (Fig. 3B) . To be sure that each assessed microscopic field contained new feather buds, we analyzed every 700 mm section from each embryo. The percentage of feather primordia in different stages of morphogenesis was assessed and identified on the basis of morphological criteria (Chuong and Widelitz, 1998) . Six stages were defined as follows: stage 0 for epithelium before placode stage, stage 1 for placodes, stage 2 for short buds, stage 3 for long buds and follicles, stage 4 for undifferentiated filaments, and stage 5 for differentiated filaments. At least 15 longitudinal featherbud sections in 25 mm 2 derived from three Fgf10-misexpressed embryos were analyzed and compared to those of 100 feather buds from three contralateral control thighs. The thickness of epidermis was assessed in paraffin sections of three skin samples from Fgf10-misexpressed thigh and in contralateral control samples, and at least 45 measurements for every group were taken using digital images and Adobe Photoshop 5.5 (Adobe Systems Inc., USA) (Fig. 3C) . The total number of early feather primordia as revealed by expression of Shh ðn ¼ 4Þ or cSnR ðn ¼ 4Þ was calculated in digital images of Fgf10-misexpressed thighs at E7.5 (stages 31-33), and was compared with that of contralateral control thigh (Fig. 3D ).
Differences were judged significant if P , 0:05, as determined by the independent Student's t-test for paired (Fig.  3A, C, D) or unpaired (Fig. 3B) samples.
